Abstract
Traumatic brain injury (TBI) can lead to short-term and long-term physical and cognitive impairments, which have significant impacts on patients, families, and society. Currently, treatment outcomes for this disease are often unsatisfactory, due at least in part to the fact that the molecular mechanisms underlying the development of TBI are largely unknown. Here, we observed significant upregulation of Piezo2, a key mechanosensitive ion channel protein, in the injured brain tissue of a mouse model of TBI induced by controlled cortical impact. Pharmacological inhibition and genetic knockdown of Piezo2 after TBI attenuated neuronal death, brain edema, brain tissue necrosis, and deficits in neural function and cognitive function. Mechanistically, the increase in Piezo2 expression contributed to TBI-induced neuronal death and subsequent production of TNF-α and IL-1β, likely through activation of the RhoA/ROCK1 pathways in the central nervous system. Our findings suggest that Piezo2 is a key player in and a potential therapeutic target for TBI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Traumatic brain injury (TBI) is a type of intracranial injury caused by direct or indirect forces acting on the head. According to the pathological changes that occur, TBI is divided into primary brain injury caused by structural disruption due to direct compression and displacement of brain tissue and consequent secondary brain injury, which involves a series of complex progressive changes such as breakdown of the blood‒brain barrier, the neuroinflammatory response, metabolic dysfunction, and neuronal death [1,2,3]. Currently, the main goal of treatment for TBI is to prevent primary injury and to block secondary damage [4]. Although a large amount of research has been conducted on the effects of various treatment strategies, such as inhibiting neuroinflammatory responses, correcting ion overload, alleviating oxidative stress, and restoring the blood‒brain barrier, the therapeutic effects of currently available treatments are still far from satisfactory [5]. The pathogenesis of TBI has become a hot topic in the fields of critical illness and neuroscience, but its pathogenesis is still far from fully understood, and there is a lack of effective treatment strategies.
Mechanical stimulation often accompanies TBI, and the conversion of mechanical information from mechanical stimuli or the surrounding environment into downstream biochemical reactions by neural cells and tissues is a complex cascade of events [6]. The main types of mechanical stimulation that can cause TBI are static hydrostatic pressure, shear force, and tensile or compressive force. Traumatic brain hematoma, edema, and other space-occupying lesion can develop in the areas surrounding brain tissue subjected to gradient static hydrostatic pressure [7, 8]. In addition, the space-occupying effect further increases intracranial pressure. All of these factors lead to an elevation of static hydrostatic pressure in brain tissue. The increase in hydrostatic pressure around neurons caused by brain edema due to TBI results in irreversible neuronal damage [6]. Moreover, during traumatic brain injury, blood from ruptured blood vessels enters the surrounding brain tissue, generating significant shear force and causing irreversible neuronal damage.
In recent years, a report in Science confirmed for the first time that Piezo family members are true mechanically sensitive ion channel proteins in mammals that mediate cytoskeleton reconstruction and stress-induced changes and play a key role in mechanical force transmission [9]. Of particular note is the recent discovery that neuronal axon growth not only is regulated by chemical signals but also depends on the regulation of mechanical force signals. Koser et al. [10] first reported in Nat Neurosci that Piezo can regulate the structure and growth direction of retinal ganglion cell (RGC) axons in Xenopus laevis. Knocking out the mechanically sensitive Piezo gene significantly changed the growth direction and structure of RGC axons. This strongly suggests that Piezo channel proteins with mechanical sensitivity in the brain may be involved in the occurrence and development of neurological disorders.
Piezo2 and Piezo1 are highly related in terms of structure [11,12,13]. Similar to Piezo1, the Piezo2 channel opens when the cell membrane is mechanically stimulated, leading to an influx of Ca2+ [14,15,16]. Ca2+ serves as the starting point for many biochemical reactions in cells, activating various downstream proteins and regulating gene expression, cellular cytoskeleton reorganization, and protein transportation [17,18,19,20]. Piezo2 is believed to interact with a range of intracellular Ca2+-response proteins [21]. This interaction can lead to specific outcomes, such as actin polymerization or the activation of transcription factors NFAT, Yap1, and β-catenin [18,19,20].
In this study, we established a controlled cortical impact (CCI) model in mice to simulate TBI and elucidated the role of mechanobiological signal transduction mediated by the neuronal mechanosensitive channel Piezo2 in TBI. The findings provide a potential target for the clinical treatment of TBI.
Methods
Experiment 1: Observation of Differences in Piezo2 Expression in Brain Tissues Between the TBI Group and Sham Group
Mice were divided into a Sham group and a TBI model group (TBI group). One day before modeling and 12 h and 1, 3, and 5 days after modeling, the neurological severity scores (NSSs) of the mice were evaluated. Each group underwent the Morris water maze (MWM) test on days 16–21. Western blotting (WB) was used to measure the expression of Piezo1 and Piezo2 in the brain tissues around the injury site and contralateral brain tissues at each time point mentioned above. Frozen brain tissue sections were prepared 3 days after TBI modeling, and single immunofluorescence staining was used to assess the expression of Piezo2, while double immunofluorescence staining was used for localization analysis of Piezo2 in microglia (Iba1), astrocytes (GFAP), and neurons (NeuN).
Experiment 2: Evaluation of the Effects of Knocking Down or Inhibiting the Function of Piezo2 in TBI Mice and Changes in the Expression of the Downstream Molecules RhoA/ROCK1
The mice were divided into the sham surgery + scramble RNA negative control (Sham + NC), model + shRNA negative control (TBI + NC), model + Piezo2-shRNA (TBI + shRNA), Sham surgery + Piezo2-shRNA (Sham + shRNA), Sham + vehicle, TBI + vehicle, TBI + D-GsMTx4, and Sham + D-GsMTx4 groups. At 3 days after TBI modeling, the NSSs of the mice were determined, followed by HE staining and Nissl staining of frozen brain tissue sections. All groups underwent the MWM test on days 16–21. WB was used to measure the protein expression of Piezo2, Iba1, GFAP, IL-1β, TNF-α, ROCK1, total RhoA, and RhoA-GTP in the brain tissue surrounding the injury in each group. Three days after modeling, double immunofluorescence staining for Piezo2 and ROCK1 or RhoA was performed.
Experimental Animals
A total of 154 healthy clean-grade C57BL/6 J mice aged 8–12 weeks and weighing 21–24 g were provided by the Animal Experimental Center of Yangzhou University and randomly assigned to groups using a random number table. The mice were housed in clean animal rooms with adequate food and water on a 12-h light/dark cycle.
Construction of a Traumatic Brain Injury Mouse Model
Mice were anesthetized with 5% isoflurane, and anesthesia was maintained with 2% isoflurane. The mouse’s head was fixed in a stereotactic frame, and a constant temperature blanket was used to maintain the body temperature at 37.0 ± 0.5 °C. A midline incision was made to expose the coronal suture, sagittal suture, and bilateral coronal ridges. A 4-mm-diameter hole was drilled in the right coronal ridge, with the center of the hole located being between the coronal suture and the coronal ridge, while keeping the dura mater intact. CCI injury was induced as previously described [22]. A PinPoint Precision Cortical Impactor PCI3000 (Hateras) with a 3-mm-diameter cylindrical impactor was used to strike the cortical surface vertically. The impact parameters used in this experiment were as follows: speed, 1.5 m/s; impact depth, 1.5 mm; and duration, 100 ms. After impact, the cortex was covered with sterile cotton, and the skin was sutured with 6–0 silk. Body temperature was maintained at 37.0 ± 0.5 °C throughout the experiment until full consciousness was restored. In the Sham group, the scalp was incised, and the skull was exposed; however, the brain was not impacted.
shRNA and D-GsMTx4 Injection
pAAV-U6-shRNA(Piezo2)-CMV-MCS-WPRE and pAAV-U6-shRNA(NC)-CMV-MCS-WPRE were designed and synthesized by Obio Technology Corporation (Shanghai, China). The Piezo2-siRNA sequence was CCTCTTCTTGTTTCAAGGGTT, and the NC-siRNA sequence was CCTAAGGTTAAGTCGCCCTCG. Injection was performed after the plasmid was packaged into an adeno-associated virus vector. D-GsMTx4 (Tocris) was dissolved in saline to a concentration of 5 μg/μl (for WB and slice staining), 10 μg/μl, or 15 μg/μl. Ten minutes after modeling, the left lateral cerebral ventricle was located using a brain stereotaxic apparatus and the following coordinates: 0.5 mm posterior to bregma, 1 mm left of bregma, and 2.5 mm below the skull surface. A hole was slowly drilled using a microperforated dental drill, and a fixed microinjector was used to inject 300 nl of the appropriate shRNA solution, 1 μl of D-GsMTx4, or an equivalent amount of scrambled shRNA or saline into each mouse. The injection time was 5 min, and the needle was left in place for 10 min after injection to ensure full absorption of the solution. The needle was slowly withdrawn, the drilling site was coated with bone wax, and the scalp was sutured.
NSSs
NSSs were used to evaluate the mice’s motor (muscle strength and abnormal movements), sensory (vision, touch, and balance), and reflex function, as described previously [23]. TBI modeling was considered successful for mice with an NSS more than 2 and 5 on the first day after modeling, with reference to a previous study [24]. A point was awarded when a mouse failed to complete a task or exhibited loss of a reflex. A higher score indicates more severe nerve damage.
MWM Test
Referring to the study of Ge et al. [25], the maze consisted of a circular tank with a diameter of 120 cm and a height of 50 cm that was filled with water dyed white with nontoxic titanium dioxide dye; the water temperature was kept at 24–26 °C, and the pool was surrounded by blue blackout curtains. The pool was divided into four quadrants, and in the fourth quadrant, there was a movable circular platform, 15 cm in diameter, submerged approximately 1 cm below the surface. The positioning navigation training phase was performed at 8:00 am every day from the 16th to 20th day after TBI; the mice were placed in the water from different quadrants for training. They were given 60 s to find the platform and were allowed to stayed on the platform for 5 s. If the platform was not found within 60 s, the mouse was guided to the platform and allowed to stay there and learn its location for 30 s. ANY-maze (Stoelting, USA) was used to obtain video recordings and data and calculate the latency of animals to reach the platform (escape latency). In the spatial exploration phase, which was performed on the 21st day after TBI modeling, the platform was removed, and the mice were placed in the third quadrant, which was farthest from the original platform location. The time the mice spent in the target quadrant, the number of times they crossed the platform, and their swimming speed over 60 s were recorded for each group.
WB
WB was used to measure target protein expression. Brain tissue surrounding the injury or matching brain tissue from mice without TBI was collected and homogenized in RIPA lysis buffer with PMSF. The sample was centrifuged at 12,000 rpm for 10 min at 4 °C, the supernatant was collected, and the protein concentration was quantified using the BCA method. Equal amounts of protein were separated by 8% SDS‒PAGE and then transferred to nitrocellulose membranes by wet transfer. After blocking with 5% skim milk for 2 h, the membranes were probed with rabbit anti-Piezo2 (Thermo Scientific, 1:500, Cat. Number: PA5-72,976), rabbit anti-Piezo1 (Thermo Scientific, 1:500, Cat. Number: MA5-32,876), rabbit anti-Iba-1 (Thermo Scientific, 1:2000, Cat. Number: PA5-27,436), rabbit anti-GFAP (Thermo Scientific, 1:1000, Cat. Number: PA5-16,291), rabbit anti-TNF-α (Cell Signaling Technology, 1:1000, Cat. Number: # 3707S), rabbit anti-IL-1β (Thermo Scientific, 1:1000, Cat. Number: P420B), rabbit anti-ROCK1 (Thermo Scientific, 1:3000, Cat. Number: PA5-22,262), rabbit anti-phospho-RhoA (Thermo Scientific, 1:2000, Cat. Number: PA5-105,763), rabbit anti-RhoA (1:1500, Cat. Number: PA5-87,403), and rabbit anti-GAPDH (Santa Cruz, 1:3000, Cat. Number: sc-365062) antibodies overnight at 4 °C. After washing with PBST, the membranes were probed with goat anti-rabbit IgG secondary antibody (Jackson ImmunoResearch, 1:3000, Cat. Number: 111–005-003) at room temperature for 2 h, and the protein bands were visualized using an enzyme-based detection system followed by scanning. The expression level of the target protein was calculated as the ratio of the gray value of the target protein band to that of the GAPDH band using ImageJ.
HE Staining and Nissl Staining
Mice were anesthetized with 5% isoflurane, and the thorax was exposed. The right atrium was cut, and PBS (40 ml) and 4% PFA (40 ml) were sequentially perfused through the left ventricle. The brain tissue was fixed in 4% PFA at 4 °C overnight and dehydrated with 15% and 30% sucrose for 24 h each, and frozen Sects. (30 μm) were obtained and subjected to HE kit (Servicebio) and Nissl staining by 0.5% toluidine blue (Servicebio) according to the instructions [26, 27]. The samples were observed and photographed under a microscope (Leica). In ImageJ, Nissl bodies were counted by randomly selecting sections at the same site from each mouse.
Immunofluorescence Staining
Immunofluorescence staining was performed according to the methods previously reported by our research group [28]. Frozen sections were blocked with PBS containing 5% goat serum and 0.3% Triton X-100 at 37 °C for 1 h and then incubated with a mixture of rabbit polyclonal anti-Piezo2 antibody (Thermo Scientific, 1:200, Cat. Number: PA5-72,976), goat polyclonal anti-NeuN antibody (Thermo Scientific, 1:500, Cat. Number: PA5-143,586), goat polyclonal anti-GFAP antibody (Thermo Scientific, 1:500, Cat. Number: PA5-143,587), goat polyclonal anti-Iba1 antibody (FUJIFILM Wako Chemicals, 1:1000, Cat. Number: 011–27991), mouse monoclonal anti-ROCK1 antibody (Thermo Scientific, 1:500, Cat. Number: MA5-27,778), and mouse monoclonal anti-RhoA antibody (Thermo Scientific, 1:500, Cat. Number: MA1-134) at 4 °C overnight. After washing, the sections were incubated with corresponding secondary antibodies, including Cy3-labeled goat anti-rabbit IgG (Jackson ImmunoResearch, 1:500, Cat. Number: 111–165-003), Cy2-labeled donkey anti-goat IgG (Jackson ImmunoResearch, 1:500, Cat. Number: 705–225-147), Cy2-labeled goat anti-rabbit lgG (Jackson ImmunoResearch, 1:500, Cat. Number: 111–225-144), and Cy3-labeled donkey anti-mouse IgG (Jackson ImmunoResearch, 1:500, Cat. Number: 715–165-150), at room temperature for 1 h. Finally, the sections were counterstained with DAPI for 1 min to label the cell nuclei. All sections were observed and photographed using a Leica DMI4000 fluorescence microscope. Cells labeled with a single probe were counted using ImageJ.
Statistical Analysis
SPSS 23.0 was used for statistical analysis. All data are presented as the mean ± standard deviation. One-way analysis of variance (ANOVA) or two-way repeated measures ANOVA followed by Bonferroni’s post hoc test was used for comparisons among multiple groups, while two independent samples were compared by two-tailed independent sample t test. P < 0.05 was considered to indicate statistical significance.
Result
Piezo2 Protein Exhibited Increased Expression After TBI and Localized to Neurons
After TBI, mice exhibit significant and sustained neurological damage. Neurological impairment appeared at 12 h post-modeling and lasted for at least 5 days (Fig. 1a). The escape latency of mice in the TBI group was higher than that of mice in the control group on the second to fifth day of the first phase of the water maze test; on the sixth day, the TBI mice stayed in the fourth quadrant, where the platform had been previously located, significantly longer than the mice in the control group, and the number of platform crossings was significantly higher in the TBI group than in the control group (Fig. 1e); there was no significant difference in swimming speed between the two groups (Supplementary Fig. 1a). We also examined the changes in the expression of Piezo family members after TBI. Immunofluorescence staining showed a significant increase in Piezo2 expression in the brain tissue surrounding the damaged area (Fig. 1b). Piezo2 expression was significantly upregulated on the injured side of the brain in TBI mice from 12 h, and this change lasted for at least 5 days; however, there was no significant change in Piezo1 expression on either side of the brain in the TBI group (Fig. 1 c and d). To further determine the cellular localization of Piezo2, double immunofluorescence staining was performed on slices of brain tissue from around the damaged area. Piezo2 was mainly expressed in neurons, with a small number of astrocytes and microglia also expressing Piezo2 (Fig. 2). TBI caused upregulation of Piezo2 expression but not Piezo1 expression in mice, which persisted higher than in normal mice. Increased Piezo2 was mainly expressed in neurons.
Effect of CCI. a Effect of CCI on NSSs. n = 3 mice/group. b Piezo2 immunofluorescence staining in the ipsilateral brain on day 3 after CCI or Sham surgery. Scale bar, 100 μm. Statistical summary of the densitometric data (right). n = 5 biological replicates/group. c, d Levels of Piezo1 and Piezo2 protein in ipsilateral (Ipsi) and contralateral (Contra) brain tissue on different days in the two groups. n = 3 biological replicates/group/time point. e MWM. The left is a heat map of mouse movement trajectories, and the right is escape latency, time spent in the target quadrant, and the number of platform crossings, listed from top to bottom. n = 6 mice/group. a–e *P < 0.05 versus the Sham group; two-tailed unpaired Student’s t test
Piezo2-shRNA Microinjection Attenuated TBI
We further explored whether shRNA-mediated inhibition of TBI-induced Piezo2 upregulation could alleviate brain damage. At 12 h after modeling, the NSS of the TBI + shRNA group was significantly lower than that of the TBI + NC group, indicating reduced neurological damage (Fig. 3d). Compared with the TBI + NC group, the TBI + shRNA group exhibited a shorter escape latency, longer time spent in the target quadrant, and increased number of platform crossings (Fig. 3e). Meanwhile, there was no significant difference in swimming speed among all the groups (Supplementary Fig. 1b). The WB results showed that Piezo2-shRNA significantly inhibited the upregulation of Piezo2, GFAP, and Iba-1 by TBI but did not completely reverse the changes (Fig. 3a and b). After Piezo2 expression was inhibited, the upregulation of proinflammatory factors by TBI was significantly suppressed. The expression levels of IL-1β and TNF-α in the TBI + shRNA group were significantly lower than those in the TBI + NC group (Fig. 3c). Under light microscopy, it was observed that TBI caused massive necrosis of cortical neurons in the damaged area, the cells in the surrounding brain tissue were loosely arranged, and intercellular edema was evident. Nuclei were condensed, and the cytoplasm was loosely arranged, exhibited lighter staining, and showed vacuolization. Nissl staining showed that the number of Nissl bodies in TBI + NC group was decreased, and Nissl staining was lighter in this group, indicating severe neuronal degeneration. Piezo2-shRNA, however, reduced the degree of damage to the lesion site and its surroundings (Supplementary Fig. 2a and b). These results suggest that Piezo2-shRNA downregulated Piezo2 expression in TBI mice and that Piezo2 knockdown reduces neuronal degeneration, inflammation, and death, as well as the degree of brain edema, and protects normal neurological function in mice to a certain extent.
Effect of microinjection of Piezo2-shRNA. a Expression of Piezo2. b Expression of Iba-1 and GFAP. c Expression of IL-1β and TNF-α. All the images are of brain tissue from the ipsilateral side. Top: representative Western blots. Bottom: statistical summary of the densitometric data. n = 3 biological replicates/group. d NSSs. n = 5 mice/group. e MWM. The top is a heat map of mouse movement trajectories, and the bottom is escape latency, time spent in the target quadrant, and the number of platform crossings, listed from left to right. n = 6 mice/group. a–e One-way ANOVA followed by Bonferroni’s post hoc test. *P < 0.05 versus the Sham + NC group. #P < 0.05 versus the TBI + NC group
Pretreatment with D-GsMTx4 Attenuated TBI
To verify whether Piezo2 aggravates TBI by increasing the intracellular calcium ion concentration and activating downstream pathways, we injected 5 µg D-GsMTx4 before TBI modeling to inhibit Piezo2 function. D-GsMTx4 did not change the expression levels of Piezo2 in the TBI or Sham group (Fig. 4a) but significantly suppressed the upregulation of GFAP and Iba-1 induced by TBI (Fig. 4b) and the increase in the expression of the proinflammatory factors IL-1β and TNF-α (Fig. 4c). NSSs showed that D-GsMTx4 improved mouse neurological function after TBI in a concentration-dependent manner, and the high concentration of D-GsMTx4 (15 μg) did not show neurotoxicity in mice (Fig. 4d). Compared with the TBI + vehicle group, the TBI + D-GsMTx4 group exhibited a shorter escape latency, longer time spent in the target quadrant, and increased number of platform crossings (Fig. 4e). Meanwhile, there was no significant difference in swimming speed among all the groups (Supplementary Fig. 1c). HE staining and Nissl staining results showed that D-GsMTx4 partially reversed brain tissue damage, neuroinflammation, and neuronal death caused by TBI (Supplementary Fig. 3a and b). These results further prove that Piezo2 activation is a key process in the development of TBI.
Effect of microinjection of D-GsMTx4. a Expression of Piezo2. b Expression of Iba-1 and GFAP. c Expression of IL-1β and TNF-α. All the images are of brain tissue from the ipsilateral side. Top: representative Western blots. Bottom: statistical summary of the densitometric data. n = 3 biological replicates/group. One-way ANOVA followed by Bonferroni’s post hoc test. d NSSs. n = 5 mice/group. One-way ANOVA followed by Bonferroni’s post hoc test. e MWM. The top is a heat map of mouse movement trajectories, and the bottom is escape latency, time spent in the target quadrant, and the number of platform crossings, listed from left to right. n = 6 mice/group. a–e One-way ANOVA followed by Bonferroni’s post hoc test. *P < 0.05 versus the Sham + vehicle group. #P < 0.05 versus the TBI + vehicle group
The Increase in Piezo2 Expression Activated RhoA/ROCK1 in the Brains of TBI Mice
To explore downstream targets of Piezo2 in the development of TBI, we studied the expression levels of proteins in the RhoA/ROCK1 signaling pathway. WB results showed that there was no significant difference in the expression level of total RhoA among the groups, but the levels of activated RhoA-GTP and its downstream target ROCK1 were significantly higher in the TBI + NC group than in the Sham + NC group; moreover, RhoA-GTP/ROCK1 levels in the TBI + shRNA group were significantly lower than that in the TBI + NC group (Fig. 5a). D-GsMTx4 also inhibited the significant increase in RhoA-GTP/ROCK1 levels in brain tissue after TBI (Fig. 5b). Double immunofluorescence staining showed that Piezo2 and RhoA/ROCK1 were coexpressed on the cell membrane (Fig. 5c). These results indicate that the RhoA/ROCK1 signaling pathway is activated after TBI and may be regulated by the increase in intracellular calcium ion concentrations caused by Piezo2.
Effect of Piezo2 on the RhoA/ROCK1 pathway. a Effect of Piezo2-shRNA on the levels of total RhoA, RhoA-GTP, and ROCK1. n = 3 biological replicates/group. One-way ANOVA followed by Bonferroni’s post hoc test. *P < 0.05 versus the Sham + NC group. #P < 0.05 versus the TBI + NC group. b Effect of D-GsMTx4 on the expression of Iba1 and GFAP. All the images are of brain tissue from the ipsilateral side. Top: representative Western blots. Bottom: statistical summary of the densitometric data. n = 3 biological replicates/group. One-way ANOVA followed by Bonferroni’s post hoc test. *P < 0.05 versus the Sham + vehicle group. #P < 0.05 versus the TBI + vehicle group. c Double immunofluorescence staining for Piezo2, RhoA, and ROCK1 in the ipsilateral brain on day 3 post-CCI. Representative samples from three biological replicates are shown. Scale bar, 100 μm
Discussion
The Piezo family currently contains two members, Piezo1 and Piezo2. Piezo1 is mainly expressed in tissues such as the lungs, bladder, and skin, while Piezo2 is mainly expressed in nervous tissues [9]. After sensing mechanical stimulation, Piezo proteins can participate in regulating a variety of physiological processes, including cell migration and differentiation, by mediating Ca2+ influx [29,30,31]. Research has found that Piezo2 channels in neuronal cells can convert mechanical stimuli into Ca2+-mediated action potentials. Specific knockout of the Piezo2 gene in neuronal cells results in the disruption of the response to mechanical stress [32]. A cell study found that knocking out Piezo2 can reduce vascular endothelial growth factor (VEGF)- or interleukin-1β (IL-1β)-mediated vascular leakage and can cause changes in intracellular Ca2+ and ATP concentrations, inhibition of Wnt11/β-catenin signaling, and disruption of vascular endothelial cell tight junction formation and vascular genesis [33]. Notably, a recent study using a TBI model found that blast shock waves can cause neuronal death, inflammatory reactions in brain tissue, and damage to the blood‒brain barrier. It was particularly found that the expression of the Piezo2 protein in brain tissue significantly increased and that the expression of the Piezo2 protein was significantly correlated with the severity of brain injury caused by blast shock waves [34]. However, the authors did not investigate the key role of Piezo2 in the pathophysiological changes in this model or the related molecular mechanism.
Our research found that Piezo2, but not Piezo1, plays a key role in TBI. Piezo2 expression increases continuously after TBI, and double immunofluorescence staining showed that this increase mainly occurs in neurons rather than astrocytes and microglia. However, it is still unknown how Piezo2 is activated after TBI. Epigenetic modifications, changes in transcription factor expression, and increased mRNA stability are potential mechanisms that require further study. Our study also found that the release of inflammatory factors, neuronal death, and neuronal function impairment after TBI can be alleviated not only by Piezo2-shRNA but also by the Piezo2-specific inhibitor D-D-GsMTx4, although the effects were not completely reversed. In addition, the effect of the inhibitor was dose dependent. D-D-GsMTx4 can effectively inhibit the opening of the Piezo2 ion channel in the cell membrane and reduce cation influx [35].
The Ras homolog gene family protein A (RhoA)/Rho-associated coil-coil containing protein kinase (ROCK) pathway is involved in various physiological activities of cells, including cytoskeleton reconstruction, contraction, migration, phagocytic adhesion, stress fiber formation, the inflammatory response, and angiogenesis, and recent studies have found it to be closely related to the polarization of microglia [36, 37]. Targeting the inhibition of the RhoA/ROCK signaling pathway has gradually become the most promising direction for the treatment of TBI, and multiple molecules, such as Nogo, CSPG, and glutamate, may be upstream molecules of this pathway [38]. A key study reported that spatial cognition can be improved after TBI by inhibiting ROCK1 upregulation [39]. These findings confirm the role of RhoA/ROCK1 in mediating TBI; however, the upstream mechanism responsible for regulating mechanical information remains unclear and requires further study.
The RhoA protein, as a small G protein, is also regulated by guanine nucleotide exchange factors (GEFs). In the resting state, RhoA binds to GDP and is biologically inactive, but after being catalyzed by GEFs, RhoA then binds to GTP and is converted to an activated state [40]. Our study found that although Piezo2-shRNA and D-D-GsMTx4 did not change the expression level of RhoA, they inhibited the activation of RhoA and downregulated the expression of ROCK1. In addition, the expression of Piezo2 and RhoA/ROCK1 was increased in the same cells in TBI mice, which further proves that the RhoA/ROCK1 pathway is a key signaling pathway mediated by Piezo2 in TBI. However, whether the increase in the levels of the proinflammatory cytokines IL-1β and TNF-α is related to the activation of the RhoA/ROCK1 pathway still needs further study.
In conclusion, our study shows, for the first time, that Piezo2 mediates the inflammatory response and neuronal degeneration and death in brain tissue and neuronal function after TBI through the use of both drug inhibitors and gene knockdown approaches. Piezo2 may be a potential target for the clinical treatment of TBI. However, Piezo2 may also be expressed in other systems and organs and participate in critical pathophysiological processes, which is one of the challenges for the broad clinical application of its inhibitors. In addition, it is worth noting that further clarification of the upstream regulatory mechanism of Piezo2 can help to elucidate the role of mechanobiological signal transduction in the pathophysiological process of TBI.
Data Availability
Not applicable.
References
Cheng P, Yin P, Ning P, Wang L, Cheng X, Liu Y, Schwebel DC, Liu J et al (2017) Trends in traumatic brain injury mortality in China, 2006–2013: a population-based longitudinal study. PLoS Med 14:e1002332. https://doi.org/10.1371/journal.pmed.1002332
Jiang JY, Gao GY, Feng JF, Mao Q, Chen LG, Yang XF, Liu JF, Wang YH et al (2019) Traumatic brain injury in China. Lancet Neurol 18:286–295. https://doi.org/10.1016/s1474-4422(18)30469-1
Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N (2014) A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med 371:2467–2476. https://doi.org/10.1056/NEJMoa1411090
Aertker BM, Bedi S, Cox CSJ (2016) Strategies for CNS repair following TBI. Exp Neurol 275(Pt 3):411–426. https://doi.org/10.1016/j.expneurol.2015.01.008
Xiong Y, Zhang Y, Mahmood A, Chopp M (2015) Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs 24:743–760. https://doi.org/10.1517/13543784.2015.1021919
Wang X, Lo EH (2003) Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol 28:229–244. https://doi.org/10.1385/mn:28:3:229
Guo T, Ren P, Hao S, Wang B (2017) The underestimated role of mechanical stimuli in brain diseases and the relate d in vitro models. Curr Pharm Des 23:2161–2176. https://doi.org/10.2174/1381612822666161027113200
Jha RM, Elmer J, Zusman BE, Desai S, Puccio AM, Okonkwo DO, Park SY, Shutter LA et al (2018) Intracranial pressure trajectories: a novel approach to informing severe traumatic brain injury phenotypes. Crit Care Med 46:1792–1802. https://doi.org/10.1097/ccm.0000000000003361
Coste B, Mathur J, Schmidt M, Earley TJ, Ranade S, Petrus MJ, Dubin AE, Patapoutian A (2010) Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 330:55–60. https://doi.org/10.1126/science.1193270
Koser DE, Thompson AJ, Foster SK, Dwivedy A, Pillai EK, Sheridan GK, Svoboda H, Viana M et al (2016) Mechanosensing is critical for axon growth in the developing brain. Nat Neurosci 19:1592–1598. https://doi.org/10.1038/nn.4394
Saotome K, Murthy SE, Kefauver JM, Whitwam T, Patapoutian A, Ward AB (2018) Structure of the mechanically activated ion channel Piezo1. Nature 554:481–486. https://doi.org/10.1038/nature25453
Zhao Q, Zhou H, Chi S et al (2018) Structure and mechanogating mechanism of the Piezo1 channel. Nature 554:487–492. https://doi.org/10.1038/nature25743
Wang L, Zhou H, Zhang M, Liu W, Deng T, Zhao Q, Li Y, Lei J et al (2019) Structure and mechanogating of the mammalian tactile channel Piezo2. Nature 573:225–229. https://doi.org/10.1038/s41586-019-1505-8
Szczot M, Liljencrantz J, Ghitani N et al (2018) Piezo2 mediates injury-induced tactile pain in mice and humans. Sci Transl Med 10:eaat9892. https://doi.org/10.1126/scitranslmed.aat9892
Szczot M, Nickolls AR, Lam RM, Chesler AT (2021) The form and function of Piezo2. Annu Rev Biochem 90:507–534. https://doi.org/10.1146/annurev-biochem-081720-023244
Chesler AT, Szczot M, Bharucha-Goebel D et al (2016) The role of Piezo2 in human mechanosensation. N Engl J Med 375:1355–1364. https://doi.org/10.1056/NEJMoa1602812
Chiang LY, Poole K, Oliveira BE, Duarte N, Sierra YA, Bruckner-Tuderman L, Koch M, Hu J et al (2011) Laminin-332 coordinates mechanotransduction and growth cone bifurcation in sensory neurons. Nat Neurosci 14:993–1000. https://doi.org/10.1038/nn.2873
Pardo-Pastor C, Rubio-Moscardo F, Vogel-González M et al (2018) Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses. Proc Natl Acad Sci USA 115:1925–1930. https://doi.org/10.1073/pnas.1718177115
Song Y, Li D, Farrelly O et al (2019) The mechanosensitive ion channel Piezo inhibits axon regeneration. Neuron 102:373-389.e6. https://doi.org/10.1016/j.neuron.2019.01.050
Zhou T, Gao B, Fan Y et al (2020) Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin. Elife 9:e52779. https://doi.org/10.7554/eLife.52779
Narayanan P, Sondermann J, Rouwette T, Karaca S, Urlaub H, Mitkovski M, Gomez-Varela D, Schmidt M (2016) Native Piezo2 interactomics identifies pericentrin as a novel regulator of Piezo2 in somatosensory neurons. J Proteome Res 15:2676–2687. https://doi.org/10.1021/acs.jproteome.6b00235
Villapol S, Loane DJ, Burns MP (2017) Sexual dimorphism in the inflammatory response to traumatic brain injury. Glia 65:1423–1438. https://doi.org/10.1002/glia.23171
Flierl MA, Stahel PF, Beauchamp KM, Morgan SJ, Smith WR, Shohami E (2009) Mouse closed head injury model induced by a weight-drop device. Nat Protoc 4:1328–1337. https://doi.org/10.1038/nprot.2009.148
Petraglia AL, Plog BA, Dayawansa S et al (2014) The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic encephalopathy. J Neurotrauma 31:1211–1224. https://doi.org/10.1089/neu.2013.3255
Ge J, Xue Z, Shu S et al (2023) MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice. JCI Insight 8:e166270. https://doi.org/10.1172/jci.insight.166270
Luo R, Fan Y, Yang J et al (2021) A novel missense variant in ACAA1 contributes to early-onset Alzheimer’s disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline. Signal Transduct Target Ther 6:325. https://doi.org/10.1038/s41392-021-00748-4
Hong P, Wang Q, Chen G (2023) Cholesterol induces inflammation and reduces glucose utilization. Open Med (Wars) 18:20230701. https://doi.org/10.1515/med-2023-0701
Huang T, Fu G, Gao J, Zhang Y, Cai W, Wu S, Jia S, Xia S et al (2020) Fgr contributes to hemorrhage-induced thalamic pain by activating NF-κB/ERK1/2 pathways. JCI Insight 5:e139987. https://doi.org/10.1172/jci.insight.139987
Cinar E, Zhou S, DeCourcey J, Wang Y, Waugh RE, Wan J (2015) Piezo1 regulates mechanotransductive release of ATP from human RBCs. Proc Natl Acad Sci USA 112:11783–11788. https://doi.org/10.1073/pnas.1507309112
Miyamoto T, Mochizuki T, Nakagomi H, Kira S, Watanabe M, Takayama Y, Suzuki Y, Koizumi S et al (2014) Functional role for Piezo1 in stretch-evoked Ca2+ influx and ATP release in urothelial cell cultures. J Biol Chem 289:16565–16575. https://doi.org/10.1074/jbc.M113.528638
Volkers L, Mechioukhi Y, Coste B (2015) Piezo channels: from structure to function. Pflugers Arch 467:95–99. https://doi.org/10.1007/s00424-014-1578-z
Eijkelkamp N, Linley JE, Torres JM et al (2013) A role for Piezo2 in EPAC1-dependent mechanical allodynia. Nat Commun 4:1682. https://doi.org/10.1038/ncomms2673
Yang H, Liu C, Zhou RM, Yao J, Li XM, Shen Y, Cheng H, Yuan J et al (2016) Piezo2 protein: a novel regulator of tumor angiogenesis and hyperpermeability. Oncotarget 7:44630–44643. https://doi.org/10.18632/oncotarget.10134
Heyburn L, Abutarboush R, Goodrich S, Urioste R, Batuure A, Statz J, Wilder D, Ahlers ST et al (2019) Repeated low-level blast overpressure leads to endovascular disruption and alterations in TDP-43 and Piezo2 in a rat model of blast TBI. Front Neurol 10:766. https://doi.org/10.3389/fneur.2019.00766
Alcaino C, Knutson K, Gottlieb PA, Farrugia G, Beyder A (2017) Mechanosensitive ion channel Piezo2 is inhibited by D-GsMTx4. Channels (Austin) 11:245–253. https://doi.org/10.1080/19336950.2017.1279370
Iring A, Tóth A, Baranyi M, Otrokocsi L, Módis LV, Gölöncsér F, Varga B, Hortobágyi T et al (2022) The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson’s disease: signalling pathway and novel therapeutic targets. Pharmacol Res 176:106045. https://doi.org/10.1016/j.phrs.2021.106045
Liu Y, Wu C, Hou Z, Fu X, Yuan L, Sun S, Zhang H, Yang D et al (2020) Pseudoginsenoside-F11 accelerates microglial phagocytosis of myelin debris and attenuates cerebral ischemic injury through complement receptor 3. Neuroscience 426:33–49. https://doi.org/10.1016/j.neuroscience.2019.11.010
Mulherkar S, Tolias KF (2020) RhoA-ROCK signaling as a therapeutic target in traumatic brain injury. Cells 9:245. https://doi.org/10.3390/cells9010245
Liu DZ, Sharp FR, Van KC, Ander BP, Ghiasvand R, Zhan X, Stamova B, Jickling GC et al (2014) Inhibition of SRC family kinases protects hippocampal neurons and improves cognitive function after traumatic brain injury. J Neurotrauma 31:1268–1276. https://doi.org/10.1089/neu.2013.3250
Hemkemeyer SA, Vollmer V, Schwarz V, Lohmann B, Honnert U, Taha M, Schnittler HJ, Bähler M (2021) Local Myo9b RhoGAP activity regulates cell motility. J Biol Chem 296:100136. https://doi.org/10.1074/jbc.RA120.013623
Acknowledgements
Deepest gratitude goes first and foremost to Bingsong Xu for technical support. Besides, we thank Yuxin Zhang and Mengsha Hu for their advice on this project.
Funding
The present study was supported by the National Natural Science Foundation of China (grant Nos. 82001170, 82101299, and 82172190).
Author information
Authors and Affiliations
Contributions
Yinggang Xiao: conceptualization, methodology, investigation, software, formal analysis. Yang Zhang: methodology, investigation, software, formal analysis. Wenjuan Yuan: methodology, investigation, software. Cunjin Wang: methodology, writing — original draft. Yali Ge: validation, formal analysis. Tianfeng Huang: visualization, project administration, funding acquisition. Ju Gao: writing — review and editing, resources, funding acquisition.
Corresponding authors
Ethics declarations
Ethics Approval
This study was approved by the Animal Ethics Committee of Yangzhou University (No. 202103405).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Yinggang Xiao, Yang Zhang, and Wenjuan Yuan contributed equally to this study.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xiao, Y., Zhang, Y., Yuan, W. et al. Piezo2 Contributes to Traumatic Brain Injury by Activating the RhoA/ROCK1 Pathways. Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04058-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12035-024-04058-y